R

Raphas Co Ltd
KOSDAQ:214260

Watchlist Manager
Raphas Co Ltd
KOSDAQ:214260
Watchlist
Price: 9 760 KRW 2.74% Market Closed
Market Cap: ₩87.1B

Raphas Co Ltd
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Raphas Co Ltd
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
R
Raphas Co Ltd
KOSDAQ:214260
Other Items
₩15.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AmorePacific Corp
KRX:090430
Other Items
-₩204B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amorepacific Group
KRX:002790
Other Items
-₩250.4B
CAGR 3-Years
N/A
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Cosmax Inc
KRX:192820
Other Items
₩7.5B
CAGR 3-Years
-48%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
LG H&H Co Ltd
KRX:051900
Other Items
-₩76.4B
CAGR 3-Years
-35%
CAGR 5-Years
20%
CAGR 10-Years
-7%
Kolmar Korea Co Ltd
KRX:161890
Other Items
-₩18.6B
CAGR 3-Years
-77%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Raphas Co Ltd
Glance View

Market Cap
87.1B KRW
Industry
Consumer products

RAPHAS Co., Ltd. engages in the research, development and sale of microarray patches. The company is headquartered in Seoul, Seoul. The company went IPO on 2019-11-11. The firm develops cosmetics based on microstructure technology. In addition, the Company sells cosmetics, pharmaceutical patches, health functional foods under the brand name of Acropass.

Intrinsic Value
3 101.31 KRW
Overvaluation 68%
Intrinsic Value
Price ₩9 760
R

See Also

What is Raphas Co Ltd's Other Items?
Other Items
15.8B KRW

Based on the financial report for Dec 31, 2024, Raphas Co Ltd's Other Items amounts to 15.8B KRW.

What is Raphas Co Ltd's Other Items growth rate?
Other Items CAGR 1Y
85%

Over the last year, the Other Items growth was 85%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett